Attention-deficit/hyperactivity disorder rating scale IV subscale analysis by visit in a European, phase 3, randomized, double-blind clinical trial of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity deficit

被引:0
|
作者
Huss, M.
Johnson, M.
Mcnicholas, F.
Van Stralen, J.
Dirks, B.
Adeyi, B.
Hervas, A.
机构
[1] Univ Gothenberg, Univ Mainz, Mainz, Germany
[2] Our Ladys Childrens Hosp, Dublin, Ireland
[3] Ctr Pediat Excellence, Boston, MA USA
[4] Shire, Dublin, Ireland
[5] Univ Hosp Mutua De Terrassa, Barcelona, Spain
关键词
D O I
暂无
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
PS-012
引用
收藏
页码:S133 / S134
页数:2
相关论文
共 50 条
  • [21] Safety and Effectiveness of Coadministration of Guanfacine Extended Release and Psychostimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Spencer, Thomas J.
    Greenbaum, Michael
    Ginsberg, Lawrence D.
    Murphy, William Rory
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (05) : 501 - 510
  • [22] The impact of adjunctive guanfacine extended release on stimulant adherence in children/adolescents with attention-deficit/hyperactivity disorder
    Meyers, Juliana
    Gajria, Kavita
    Candrilli, Sean D.
    Fridman, Moshe
    Sikirica, Vanja
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2017, 6 (02) : 109 - 125
  • [23] Response/Remission With Guanfacine Extended-Release and Psychostimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
    Cutler, Andrew J.
    Brams, Matthew
    Bukstein, Oscar
    Mattingly, Gregory
    McBurnett, Keith
    White, Carla
    Rubin, Jonathan
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2014, 53 (10): : 1092 - 1101
  • [24] Distinguishing the efficacy and sedative effects of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder
    Huss, Michael
    McBurnett, Keith
    Cutler, Andrew J.
    Hervas, Amaia
    Bliss, Caleb
    Gao, Joseph
    Dirks, Bryan
    Newcorn, Jeffrey H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 (03) : 432 - 443
  • [25] Extended-release medications for children and adolescents with attention-deficit hyperactivity disorder
    Feldman, M.
    Belanger, S.
    PAEDIATRICS & CHILD HEALTH, 2009, 14 (09) : 593 - 596
  • [26] Dexmethylphenidate extended release - In attention-deficit hyperactivity disorder
    Robinson, Dean M.
    Keating, Gillian M.
    DRUGS, 2006, 66 (05) : 661 - 668
  • [27] Ginkgo biloba for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized controlled trial
    Salehi, Bahman
    Imani, Reza
    Mohammadi, Mohammad Reza
    Fallah, Jalil
    Mohammadi, Mohammad
    Ghanizadeh, Ahmad
    Tasviechi, Ali Akbar
    Vossoughi, Ardalan
    Rezazadeh, Shams-Ali
    Akhondzadeh, Shahin
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (01): : 76 - 80
  • [28] Efficacy of Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder
    Newcorn, Jeffrey H.
    Huss, Michael
    Connor, Daniel F.
    Hervas, Amaia
    Werner-Kiechle, Tamara
    Robertson, Brigitte
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2020, 41 (07): : 565 - 570
  • [29] Attention-Deficit/Hyperactivity symptoms in Icelandic schoolchildren:: Assessment with the Attention Deficit/Hyperactivity Rating Scale-IV
    Magnússon, P
    Smári, J
    Grétarsdóttir, H
    Prándardóttir, H
    SCANDINAVIAN JOURNAL OF PSYCHOLOGY, 1999, 40 (04) : 301 - 306
  • [30] Attention-deficit/hyperactivity Disorder and Suicidality in Children and Adolescents
    Balazs, J.
    Miklosi, M.
    Kereszteny, A.
    Dallos, G.
    Gadoros, J.
    EUROPEAN PSYCHIATRY, 2015, 30